Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders

Frontiers in Bioscience

Volumn 12, Issue 3, 2007, Pages 800-815

  Touw, Ivo P ^a   Van De Geijn, Gert Jan M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

GCSF; Granulocyte colony stimulating factor; Granulopoiesis; Neutropenia; Review; Signal transduction

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 34249828162     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2103     Document Type: Review

References (184)

1. Wells, J. A., and A. M. de Vos: Hematopoietic receptor complexes. Annu Rev Biochem 65, 609-634 (1996)
2. Demetri, G. D., and J. D. Griffin: Granulocyte colony-stimulating factor and its receptor. [Review] [170 refs]. Blood 78, 2791-2808 (1991)
3. Berliner, N., A. Hsing, T. Graubert, F. Sigurdsson, M. Zain, E. Bruno, and R. Hoffman: Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 85, 799-803 (1995)
4. Lieschke, G. J.: CSF-deficient mice - what have they taught us?. [Review] [41 refs]. Ciba Found Symp 204, 60-74 (1997)
5. Lieschke, G. J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan, and A. R. Dunn: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746 (1994)
6. Liu, F., H. Y. Wu, R. Wesselschmidt, T. Kornaga, and D. C. Link: Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491-501 (1996)
7. Zhan, Y., G. J. Lieschke, D. Grail, A. R. Dunn, and C. Cheers: Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91, 863-869 (1998)
8. Hermans, M. H., G. J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward, and I. P. Touw: Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 101, 2584-2590 (2003)
9. Avalos, B. R., J. C. Gasson, C. Hedvat, S. G. Quan, G. C. Baldwin, R. H. Weisbart, R. E. Williams, D. W. Golde, and J. F. DiPersio: Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 75, 851-857 (1990)
10. Sato, N., S. Asano, H. P. Koeffler, S. Yoshida, F. Takaku, and O. Takatani: Identification of neutrophil alkaline phosphatase-inducing factor in cystic fluid of a human squamous cell carcinoma as granulocyte colony-stimulating factor. J Cell Physiol 137, 272-276 (1988)
11. Dale, D. C.: Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia. J Support Oncol 3, 39-41 (2005)
12. Lowenberg, B., W. van Putten, M. Theobald, J. Gmur, L. Verdonck, P. Sonneveld, M. Fey, H. Schouten, G. de Greef, A. Ferrant, T. Kovacsovics, A. Gratwohl, S. Daenen, P. Huijgens, and M. Boogaerts: Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 349, 743-752 (2003)
13. Amadori, S., S. Suciu, U. Jehn, R. Stasi, X. Thomas, J. P. Marie, P. Muus, F. Lefrere, Z. Bememan, G. Fillet, C. Denzlinger, R. Willemze, P. Leoni, G. Leone, M. Casini, F. Ricciuti, M. Vignetti, F. Beeldens, F. Mandelli, and T. De Witte: Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. Blood 106, 27-34 (2005)
14. Dale, D. C., T. E. Cottle, C. J. Fier, A. A. Bolyard, M. A. Bonilla, L. A. Boxer, B. Cham, M. H. Freedman, G. Kannourakis, S. E. Kinsey, R. Davis, D. Scarlata, B. Schwinzer, C. Zeidler, and K. Weite: Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 72, 82-93 (2003)
15. Weite, K., C. Zeidler, A. Reiter, W. Muller, E. Odenwald, L. Souza, and H. Riehm: Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75, 1056-1063 (1990)
16. Welte, K., and L. A. Boxer: Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol 34, 267-278 (1997)
17. Molineux, G., Z. Pojda, I. N. Hampson, B. I. Lord, and T. M. Dexter: Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 76, 2153-2158 (1990)
18. Lapidot, T., and I. Petit: Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30, 973-981 (2002)
19. Thomas, J., F. Liu, and D. C. Link: Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol 9, 183-189 (2002)
20. Semerad, C. L., M. J. Christopher, F. Liu, B. Short, P. J. Simmons, I. Winkler, J. P. Levesque, J. Chappel, F. P. Ross, and D. C. Link: G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106, 3020-3027 (2005)
21. Semerad, C. L., F. Liu, A. D. Gregory, K. Stumpf, and D. C. Link: G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17, 413-423 (2002)
22. Harada, M., Y. Qin, H. Takano, T. Minamino, Y. Zou, H. Toko, M. Ohtsuka, K. Matsuura, M. Sano, J. Nishi, K. Iwanaga, H. Akazawa, T. Kunieda, W. Zhu, H. Hasegawa, K. Kunisada, T. Nagai, H. Nakaya, K. Yamauchi-Takihara, and I. Komuro: G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11, 305-311 (2005)
23. Li, Y., G. Takemura, H. Okada, S. Miyata, M. Esaki, R. Maruyama, H. Kanamori, L. Li, A. Ogino, Y. Misao, N. C. Khai, A. Mikami, S. Minatoguchi, T. Fujiwara, and H. Fujiwara: Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Lab Invest 86, 32-44 (2006)
24. Schneider, A., C. Kruger, T. Steigleder, D. Weber, C. Pitzer, R. Laage, J. Aronowski, M. H. Maurer, N. Gassler, W. Mier, M. Hasselblatt, R. Kollmar, S. Schwab, C. Sommer, A. Bach, H. G. Kuhn, and W. R. Schabitz: The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115, 2083-2098 (2005)
25. Bazan, J. F.: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A 87, 6934-6938 (1990)
26. Cosman, D.: The hematopoietin receptor superfamily. Cytokine 5, 95-106 (1993)
27. Fukunaga, R., E. Ishizaka-Ikeda, Y. Seto, and S. Nagata: Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 61, 341-350 (1990)
28. Bravo, J., and J. K. Heath: Receptor recognition by gp130 cytokines. Embo J 19, 2399-2411 (2000)
29. Aritomi, M., N. Kunishima, T. Okamoto, R. Kuroki, Y. Ota, and K. Morikawa: Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme. Nature 401, 713-717 (1999)
30. Layton, J. E., N. E. Hall, F. Connell, J. Venhorst, and H. R. Treutlein: Identification of ligand-binding site III on the immunoglobulin-like domain of the granulocyte colony-stimulating factor receptor. J Biol Chem 276, 36779-36787. (2001)
31. Kurth, I., U. Horsten, S. Pflanz, A. Timmermann, A. Kuster, H. Dahmen, I. Tacken, P. C. Heinrich, and G. Muller-Newen: Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J Immunol 164, 273-282 (2000)
32. Fukunaga, R., E. Ishizaka-Ikeda, C. X. Pan, Y. Seto, and S. Nagata: Functional domains of the granulocyte colony-stimulating factor receptor. Embo J 10, 2855-2865 (1991)
33. Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga, and T. Kishimoto: Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 88, 11349-11353 (1991)
34. Barge, R. M., J. P. de Koning, K. Pouwels, F. Dong, B. Lowenberg, and I. P. Touw: Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. Blood 87, 2148-2153 (1996)
35. Dong, F., C. van Buitenen, K. Pouwels, L. H. Hoefsloot, B. Lowenberg, and I. P. Touw: Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13, 7774-7781 (1993)
36. Fukunaga, R., E. Ishizaka-Ikeda, and S. Nagata: Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 74, 1079-1087 (1993)
37. Santini, V., B. Scappini, Z. K. Indik, A. Gozzini, P. R. Ferrini, and A. D. Schreiber: The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal. Blood 101, 4615-4622 (2003)
38. Morikawa, K., S. Morikawa, M. Nakamura, and T. Miyawaki: Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br J Haematol 118, 296-304. (2002)
39. Khwaja, A., J. Carver, H. M. Jones, D. Paterson, and D. C. Linch: Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells. Br J Haematol 85, 254-259 (1993)
40. Hanazono, Y., T. Hosoi, T. Kuwaki, S. Matsuki, K. Miyazono, K. Miyagawa, and F. Takaku: Structural analysis of the receptors for granulocyte colony-stimulating factor on neutrophils. Exp Hematol 18, 1097-1103 (1990)
41. Shimoda, K., S. Okamura, N. Harada, S. Kondo, T. Okamura, and Y. Niho: Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 91, 1310-1313 (1993)
42. Boneberg, E. M., L. Hareng, F. Gantner, A. Wendel, and T. Hartung: Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 95, 270-276 (2000)
43. Budel, L. M., I. P. Touw, R. Delwel, and B. Lowenberg: Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 74, 2668-2673 (1989)
44. Corcione, A., M. V. Corrias, S. Daniele, S. Zupo, M. Spriano, and V. Pistoia: Expression of granulocyte colony-stimulating factor and granulocyte colony-stimulating factor receptor genes in partially overlapping monoclonal B-cell populations from chronic lymphocytic leukemia patients. Blood 87, 2861-2869 (1996)
45. Matsushita, K., and N. Arima: Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells. Leak Lymphoma 31, 295-304 (1998)
46. Morikawa, K., S. Morikawa, T. Miyawaki, M. Nagasaki, I. Torii, and K. Imai: Constitutive expression of granulocyte-colony stimulating factor receptor on a human B-lymphoblastoid cell line. Br J Haematol 94, 250-257 (1996)
47. Tsuchiya, H., S. S. el-Sonbaty, M. Watanabe, H. Suzushima, N. Asou, T. Murakami, T. Takeda, A. Shimosaka, K. Takatsuki, and I. Matsuda: Analysis of myeloid characteristics in acute lymphoblastic leukemia. Leuk Res 17, 809-813 (1993)
48. McCracken, S., J. E. Layton, S. C. Shorter, P. M. Starkey, D. H. Barlow, and H. J. Mardon: Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta. J Endocrinol 149, 249-258 (1996)
49. McCracken, S. A., K. E. Grant, I. Z. MacKenzie, C. W. Redman, and H. J. Mardon: Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol Reprod 60, 790-796 (1999)
50. Calhoun, D. A., W. H. Donnelly, Jr., Y. Du, J. B. Dame, Y. Li, and R. D. Christensen: Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus [In Process Citation]. Pediatr Res 46, 333-338 (1999)
51. Schneider, A., H. G. Kuhn, and W. R. Schabitz: A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4, 1753-1757 (2005)
52. Larsen, A., T. Davis, B. M. Curtis, S. Gimpel, J. E. Sims, D. Cosman, L. Park, E. Sorensen, C. J. March, and C. A. Smith: Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. Br J Haematol 77, 54-59 (1991)
53. Fukunaga, R., Y. Seto, S. Mizushima, and S. Nagata: Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci U S A 87, 8702-8706 (1990)
54. Dong, F., M. van Paassen, C. van Buitenen, L. H. Hoefsloot, B. Lowenberg, and I. P. Touw: A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform. Blood 85, 902-911 (1995)
55. Ihle, J. N.: The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol 60, 1-35 (1995)
56. Ihle, J. N.: Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. [Review] [263 refs]. Adv Cancer Res 68, 23-65 (1996)
57. Ihle, J. N., T. Nosaka, W. Thierfelder, F. W. Quelle, and K. Shimoda: Jaks and Stats in cytokine signaling. [Review] [48 refs]. Stem Cells 1, 105-111 (1997)
58. Nicholson, S. E., A. C. Dates, A. G. Harpur, A. Ziemiecki, A. F. Wilks, and J. E. Layton: Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci USA 91, 2985-2988 (1994)
59. Shimoda, K., H. Iwasaki, S. Okamura, Y. Ohno, A. Kubota, F. Arima, T. Otsuka, and Y. Niho: G-CSF induces tyrosine phosphorylation of the JAK2 protein in the human myeloid G-CSF responsive and proliferative cells, but not in mature neutrophils. Biochem Biophys Res Commun 203, 922-928 (1994)
60. Shimoda, K., J. Feng, H. Murakami, S. Nagata, D. Watling, N. C. Rogers, G. R. Stark, I. M. Kerr, and J. N. Ihle: Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 90, 597-604 (1997)
61. Tian, S. S., P. Lamb, H. M. Seidel, R. B. Stein, and J. Rosen: Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84, 1760-1764 (1994)
62. Tian, S. S., P. Tapley, C. Sincich, R. B. Stein, J. Rosen, and P. Lamb: Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STATS, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 88, 4435-4444 (1996)
63. de Koning, J. P., A. A. Soede-Bobok, A. M. Schelen, L. Smith, D. van Leeuwen, V. Santini, B. M. Burgering, J. L. Bos, B. Lowenberg, and I. P. Touw: Proliferation signaling and activation of She, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 91, 1924-1933 (1998)
64. Dong, F., and A. C. Larner: Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 95, 1656-1662. (2000)
65. Hunter, M. G., and B. R. Avalos: Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol 160, 4979-4987 (1998)
66. Ward, A. C., L. Smith, J. P. de Koning, Y. van Aesch, and I. P. Touw: Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells. J Biol Chem 274, 14956-14962 (1999)
67. Corey, S. J., P. M. Dombrosky-Ferlan, S. Zuo, E. Krohn, A. D. Donnenberg, P. Zorich, G. Romero, M. Takata, and T. Kurosaki: Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem 273, 3230-3235 (1998)
68. Dombrosky-Ferlan, P. M., and S. J. Corey: Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase. Oncogene 14, 2019-2024 (1997)
69. Grishin, A., S. Sinha, V. Roginskaya, M. J. Boyer, J. Gomez-Cambronero, S. Zuo, T. Kurosaki, G. Romero, and S. J. Corey: Involvement of She and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Oncogene 19, 97-105 (2000)
70. Sinha, S., J. Jancarik, V. Roginskaya, K. Rothermund, L. M. Boxer, and S. J. Corey: Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl. Exp Hematol 29, 746-755 (2001)
71. Zhu, Q. S., L. Xia, G. B. Mills, C. A. Lowell, I. P. Touw, and S. J. Corey: G-CSF induced reactive oxygen species involves Lyn-PI 3-kinase-Akt and contributes to myeloid cell growth. Blood, (2005)
72. Rodig, S. J., M. A. Meraz, J. M. White, P. A. Lampe, J. K. Riley, C. D. Arthur, K. L. King, K. C. Sheehan, L. Yin, D. Pennica, E. M. Johnson, Jr., and R. D. Schreiber: Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373-383 (1998)
73. de Koning, J. P., F. Dong, L. Smith, A. M. Schelen, R. M. Barge, D. C. van der Plas, L. H. Hoefsloot, B. Lowenberg, and I. P. Touw: The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 87, 1335-1342 (1996)
74. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber: Targeted disruption of the Stall gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442 (1996)
75. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy: Targeted disruption of the mouse Stal1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450 (1996)
76. Chakraborty, A., K. F. Dyer, M. Cascio, T. A. Mietzner, and D. J. Tweardy: Identification of a novel Stat3 recruitment and activalion motif within the granulocyte colony-stimulating factor receptor. Blood 93, 15-24 (1999)
77. Ward, A. C., M. H. Hermans, L. Smith, Y. M. van Aesch, A. M. Schelen, C. Antonissen, and I. P. Touw: Tyrosine-dependent and -independent mechanisms of STATS activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood 93, 113-124 (1999)
78. Akbarzadeh, S., A. C. Ward, D. O. McPhee, W. S. Alexander, G. J. Lieschke, and J. E. Layton: Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells. Blood 99, 879-887 (2002)
79. Shimozaki, K., K. Nakajima, T. Hirano, and S. Nagata: Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem 212, 25184-25189 (1997)
80. de Koning, J. P., A. A. Soede-Bobok, A. C. Ward, A. M. Schelen, C. Antonissen, D. van Leeuwen, B. Lowenberg, and I. P. Touw: STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene 19, 3290-3298 (2000)
81. Sherr, C. J., and J. M. Roberts: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9, 1149-1163 (1995)
82. Lee, C. K., R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. Takeshita, R. A. DePinho, and D. E. Levy: STATS is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63-72 (2002)
83. McLemore, M. L., S. Grewal, F. Liu, A. Archambault, J. Poursine-Laurent, J. Haug, and D. C. Link: STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204 (2001)
84. Hermans, M. H., C. Antonissen, A. C. Ward, A. E. Mayen, R. E. Ploemacher, and I. P. Touw: Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G- CSF receptor gene. J Exp Med 189, 683-692 (1999)
85. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr.: Stat3 as an oncogene. Cell 98, 295-303 (1999)
86. Kops, G. J., N. D. de Ruiter, A. M. De Vries-Smits, D. R. Powell, J. L. Bos, and B. M. Burgering: Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630-634 (1999)
87. Medema, R. H., G. J. Kops, J. L. Bos, and B. M. Burgering: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782-787 (2000)
88. Dong, F., X. Liu, J. P. de Koning, I. P. Touw, L. Henninghausen, A. Larner, and P. M. Grimley: Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J Immunol 161, 6503-6509 (1998)
89. Fujitani, Y., M. Hibi, T. Fukada, M. Takahashi-Tezuka, H. Yoshida, T. Yamaguchi, K. Sugiyama, Y. Yamanaka, K. Nakajima, and T. Hirano: An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Oncogene 14, 751-761 (1997)
90. Ward, A. C., Y. M. van Aesch, A. M. Schelen, and I. P. Touw: Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood 93, 447-458 (1999)
91. Teglund, S., C. McKay, E. Schuetz, J. M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. N. Ihle: Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850 (1998)
92. Saxton, T. M., M. Henkemeyer, S. Gasca, R. Shen, D. J. Rossi, F. Shalaby, G. S. Feng, and T. Pawson: Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. Embo J 16, 2352-2364 (1997)
93. Avalos, B. R.: The granulocyte colony-stimulating factor receptor and its role in disorders of granulopoiesis. Leuk Lymphoma 28, 265-273 (1998)
94. Avalos, B. R., J. M. Parker, D. A. Ware, M. G. Hunter, K. A. Sibert, and B. J. Druker: Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils. Exp Hematol 25, 160-168 (1997)
95. Bjorbaek, C., R. M. Buchholz, S. M. Davis, S. H. Bates, D. D. Pierroz, H. Gu, B. G. Neel, M. G. Myers, Jr., and J. S. Flier: Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 276, 4747-4755 (2001)
96. Hof, P., S. Pluskey, S. Dhe-Paganon, M. J. Eck, and S. E. Shoelson: Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450 (1998)
97. Niu, G., R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove, and H. Yu: Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res 59, 5059-5063 (1999)
98. Ancey, C., A. Kuster, S. Haan, A. Herrmann, P. C. Heinrich, and G. Muller-Newen: A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor. J Biol Chem 278, 16968-16972 (2003)
99. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto: Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929 (1997)
100. You, M., D. H. Yu, and G. S. Feng: Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19, 2416-2424 (1999)
101. Ali, S., Z. Nouhi, and N. Chughtai: SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J Biol Chem 278, 52021-52031 (2003)
102. Cunnick, J. M., S. Meng, Y. Ren, C. Desponts, H. G. Wang, J. Y. Djeu, and J. Wu: Regulation of the mitogen-activated protein kinase signaling pathway by SHP2. J Biol Chem 277, 9498-9504 (2002)
103. Kendrick, T. S., R. J. Lipscombe, O. Rausch, S. E. Nicholson, J. E. Layton, L. C. Goldie-Cregan, and M. A. Bogoyevitch: Contribution of the membrane-distal tyrosine in intracellular signaling by the granulocyte colony-stimulating factor receptor. J Biol Chem 279, 326-340 (2004)
104. van de Geijn, G. J., J. Gits, L. H. Aarts, C. Heijmans-Antonissen, and I. P. Touw: G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STATS but leave suppression of STAT3 intact. Blood 104, 667-674 (2004)
105. de Koning, J. P., A. M. Schelen, F. Dong, C. van Buitenen, B. M. Burgering, J. L. Bos, B. Lowenberg, and I. P. Touw: Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes. Blood 87, 132-140 (1996)
106. Rausch, O., and C. J. Marshall: Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol 17, 1170-1179 (1997)
107. van der Geer, P., S. Wiley, G. D. Gish, and T. Pawson: The She adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr Biol 6, 1435-1444 (1996)
108. Harmer, S. L., and A. L. DeFranco: She contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Mol Cell Biol 17, 4087-4095 (1997)
109. Vogel, W., and A. Ullrich: Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. Cell Growth Differ 7, 1589-1597 (1996)
110. Bennett, A. M., T. L. Tang, S. Sugimoto, C. T. Walsh, and B. G. Neel: Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras. Proc Natl Acad Sci U S A 91, 7335-7339 (1994)
111. Bashey, A., L. Healy, and C. J. Marshall: Proliferative but not nonproliferative responses to granulocyte colony-stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood 83, 949-957 (1994)
112. Muszynski, K. W., F. W. Ruscetti, G. Heidecker, U. Rapp, J. Troppmair, J. M. Gooya, and J. R. Keller: Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells. J Exp Med 181, 2189-2199 (1995)
113. Keller, J. R., F. W. Ruscetti, G. Heidecker, D. M. Linnekin, U. Rapp, J. Troppmair, J. Gooya, and K. W. Muszynski: The effect of c-raf antisense oligonucleotides on growth factor-induced proliferation of hematopoietic cells. Curr Top Microbiol Immunol 211, 43-53 (1996)
114. Rausch, O., and C. J. Marshall: Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. J Biol Chem 274, 4096-4105 (1999)
115. Baumann, M. A., C. C. Paul, S. Lemley-Gillespie, M. Oyster, and J. Gomez-Cambronero: Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing. Am J Hematol 68, 99-105. (2001)
116. Darley, R. L., and A. K. Burnett: Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors. Exp Hematol 27, 1599-1608 (1999)
117. Koay, D. C., T. Nguyen, and A. C. Sartorelli: Distinct region of the granulocyte colony-stimulating factor receptor mediates proliferative signaling through activation of Janus kinase 2 and p44/42 mitogen-activated protein kinase. Cell Signal 14, 239-247 (2002)
118. Dong, F., J. S. Gutkind, and A. C. Larner: Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by proteintyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. J Biol Chem 276, 10811-10816. (2001)
119. Hunter, M. G., and B. R. Avalos: Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 95, 2132-2137. (2000)
120. David, M., H. E. Chen, S. Goelz, A. C. Larner, and B. G. Neel: Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15, 7050-7058 (1995)
121. Shimoda, K., S. Okamura, N. Harada, and Y. Niho: Detection of the granulocyte colony-stimulating factor receptor using biotinylated granulocyte colony-stimulating factor: presence of granulocyte colony-stimulating factor receptor on CD34-positive hematopoietic progenitor cells. Res Exp Med 192, 245-255 (1992)
122. Tsui, H. W., K. A. Siminovitch, L. de Souza, and F. W. Tsui: Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4, 124-129 (1993)
123. Kozlowski, M., I. Mlinaric-Rascan, G. S. Feng, R. Shen, T. Pawson, and K. A. Siminovitch: Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med 178, 2157-2163 (1993)
124. Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and D. R. Beier: Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73, 1445-1454 (1993)
125. Tapley, P., N. K. Shevde, P. A. Schweitzer, M. Gallina, S. W. Christianson, I. L. Lin, R. B. Stein, L. D. Shultz, J. Rosen, and P. Lamb: Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp Hematol 25, 122-131(1997)
126. Ward, A. C., S. P. Oomen, L. Smith, J. Gits, D. van Leeuwen, A. A. Soede-Bobok, C. A. Erpelinck-Verschueren, T. Yi, and I. P. Touw: The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. Leukemia 14, 1284-1291 (2000)
127. Dong, F., Y. Qiu, T. Yi, I. P. Touw, and A. C. Larner: The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol 167, 6447-6452 (2001)
128. Helgason, C. D., J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal, and R. K. Humphries: Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12, 1610-1620 (1998)
129. Fujimoto, M., and T. Naka: Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 24, 659-666 (2003)
130. Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, S. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and A. Yoshimura: The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. Embo J 18, 1309-1320 (1999)
131. Nicholson, S. E., T. A. Willson, A. Parley, R. Starr, J. G. Zhang, M. Baca, W. S. Alexander, D. Metcalf, D. J. Hilton, and N. A. Nicola: Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. Embo J 18, 375-385 (1999)
132. Liu, Q., T. Sasaki, I. Kozieradzki, A. Wakeham, A. Itie, D. J. Dumont, and J. M. Penninger: SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 13, 786-791 (1999)
133. Catlett-Falcone, R., W. S. Dalton, and R. Jove: STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription. Curr Opin Oncol 11, 490-496 (1999)
134. Giordanetto, F., and R. T. Kroemer: A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1). Protein Eng 16, 115-124 (2003)
135. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924 (1997)
136. Eyckerman, S., D. Broekaert, A. Verhee, J. Vandekerckhove, and J. Tavernier: Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor. FEBS Lett 486, 33-37 (2000)
137. Schmitz, J., M. Weissenbach, S. Haan, P. C. Heinrich, and F. Schaper: SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem 275, 12848-12856 (2000)
138. Nicholson, S. E., D. De Souza, L. J. Fabri, J. Corbin, T. A. Willson, J. G. Zhang, A. Silva, M. Asimakis, A. Parley, A. D. Nash, D. Metcalf, D. J. Hilton, N. A. Nicola, and M. Baca: Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci USA 97, 6493-6498 (2000)
139. Cohney, S. J., D. Sanden, N. A. Cacalano, A. Yoshimura, A. Mui, T. S. Migone, and J. A. Johnston: SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STATS phosphorylation and lymphocyte proliferation.
140. Hortner, M., U. Nielsch, L. M. Mayr, J. A. Johnston, P. C. Heinrich, and S. Haan: Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol 169, 1219-1227 (2002)
141. Zhuang, D., Y. Qiu, S. J. Haque, and F. Dong: Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1. J Leukoc Biol 78, 1008-1015 (2005)
142. Zhang, J. G., A. Farley, S. E. Nicholson, T. A. Willson, L. M. Zugaro, R. J. Simpson, R. L. Moritz, D. Cary, R. Richardson, G. Hausmann, B. J. Kile, S. B. Kent, W. S. Alexander, D. Metcalf, D. J. Hilton, N. A. Nicola, and M. Baca: The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 96, 2071-2076 (1999)
143. Kamura, T., S. Sato, D. Haque, L. Liu, W. G. Kaelin, Jr., R. C. Conaway, and J. W. Conaway: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12, 3872-3881 (1998)
144. Ungureanu, D., P. Saharinen, I. Junttila, D. J. Hilton, and O. Silvennoinen: Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol 22, 3316-3326 (2002)
145. Kamizono, S., T. Hanada, H. Yasukawa, S. Minoguchi, R. Kato, M. Minoguchi, K. Hattori, S. Hatakeyama, M. Yada, S. Morita, T. Kitamura, H. Kato, K. Nakayama, and A. Yoshimura: The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 276, 12530-12538 (2001)
146. Narazaki, M., M. Fujimoto, T. Matsumoto, Y. Morita, H. Saito, T. Kajita, K. Yoshizaki, T. Naka, and T. Kishimoto: Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc Natl Acad Sei USA 95, 13130-13134 (1998)
147. Zhang, J. G., D. Metcalf, S. Rakar, M. Asimakis, C. J. Greenhalgh, T. A. Willson, R. Starr, S. E. Nicholson, W. Carter, W. S. Alexander, D. J. Hilton, and N. A. Nicola: The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc Natl Acad Sci USA 98, 13261-13265 (2001)
148. Lehmann, U., J. Schmitz, M. Weissenbach, R. M. Sobota, M. Hortner, K. Friederichs, I. Behrmann, W. Tsiaris, A. Sasaki, J. Schneider-Mergener, A. Yoshimura, B. G. Neel, P. C. Heinrich, and F. Schaper: SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J Biol Chem 278, 661-671 (2003)
149. Auernhammer, C. J., C. Bousquet, and S. Melmed: Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 96, 6964-6969 (1999)
150. Davey, H. W., M. J. McLachlan, R. J. Wilkins, D. J. Hilton, and T. E. Adams: STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol Cell Endocrinol 158, 111-116 (1999)
151. Yasukawa, H., A. Sasaki, and A. Yoshimura: Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18, 143-164 (2000)
152. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton: A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921 (1997)
153. van de Geijn, G. J., J. Gits, and I. P. Touw: Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. JLeukoc Biol 76, 237-244 (2004)
154. Hunter, M. G., A. Jacob, C. O'Donnell L, A. Agler, L. J. Druhan, K. M. Coggeshall, and B. R. Avalos: Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J Immunol 173, 5036-5045 (2004)
155. Tannahill, G. M., J. Elliott, A. C. Barry, L. Hibbert, N. A. Cacalano, and J. A. Johnston: SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol Cell Biol 25, 9115-9126 (2005)
156. Croker, B. A., D. Metcalf, L. Robb, W. Wei, S. Mifsud, L. DiRago, L. A. Cluse, K. D. Sutherland, L. Hartley, E. Williams, J. G. Zhang, D. J. Hilton, N. A. Nicola, W. S. Alexander, and A. W. Roberts: SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20, 153-165 (2004)
157. Kimura, A., I. Kinjyo, Y. Matsumura, H. Mori, R. Mashima, M. Harada, K. R. Chien, H. Yasukawa, and A. Yoshimura: SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J Biol Chem 279, 6905-6910 (2004)
158. Ohya, K., S. Kajigaya, Y. Yamashita, A. Miyazato, K. Hatake, Y. Miura, U. Ikeda, K. Shimada, K. Ozawa, and H. Mano: SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J Biol Chem 272, 27178-27182 (1997)
159. De Sepulveda, P., K. Okkenhaug, J. L. Rose, R. G. Hawley, P. Dubreuil, and R. Rottapel: Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. Embo J 18, 904-915 (1999)
160. Minoo, P., M. M. Zadeh, R. Rottapel, J. J. Lebrun, and S. Ali: A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 103, 1398-1407 (2004)
161. Masuhara, M., H. Sakamoto, A. Matsumoto, R. Suzuki, H. Yasukawa, K. Mitsui, T. Wakioka, S. Tanimura, A. Sasaki, H. Misawa, M. Yokouchi, M. Ohtsubo, and A. Yoshimura: Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun 239, 439-446 (1997)
162. Cacalano, N. A., D. Sanden, and J. A. Johnston: Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell Biol 3, 460-465 (2001)
163. Bjorbak, C., H. J. Lavery, S. H. Bates, R. K. Olson, S. M. Davis, J. S. Flier, and M. G. Myers, Jr.: SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275, 40649-40657 (2000)
164. Bartoe, J. L., and N. M. Nathanson: Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor. Brain Res Mol Brain Res 107, 108-119 (2002)
165. Mahboubi, K., N. C. Kirkiles-Smith, J. Karras, and J. S. Pober: Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3. J Biol Chem 278, 25014-25023 (2003)
166. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano: Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STATS in anti-apoptosis. Immunity 5, 449-460 (1996)
167. Yu, C. L., Y. J. Jin, and S. J. Burakoff: Cytosolic tyrosine dephosphorylation of STATS. Potential role of SHP-2 in STATS regulation. J Biol Chem 275, 599-604 (2000)
168. Chen, Y., R. Wen, S. Yang, J. Schuman, E. E. Zhang, T. Yi, G. S. Feng, and D. Wang: Identification of Shp-2 as a Stat5A phosphatase. J Biol Chem 278, 16520-16527 (2003)
169. Aarts, L. H., O. Roovers, A. C. Ward, and I. P. Touw: Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics. Blood 103, 571-579 (2004)
170. Dong, F., D. C. Dale, M. A. Bonilla, M. Freedman, A. Fasth, H. J. Neijens, J. Palmblad, G. L. Briars, G. Carlsson, A. J. Veerman, K. Welte, B. Lowenberg, and I. P. Touw: Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 11, 120-125 (1997)
171. Dong, F., R. K. Brynes, N. Tidow, K. Welte, B. Lowenberg, and I. P. Touw: Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia [see comments]. N Engl J Med 333, 487-493 (1995)
172. Freedman, M. H., and B. P. Alter: Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol 39, 128-133 (2002)
173. Hermans, M. H., A. C. Ward, C. Antonissen, A. Karis, B. Lowenberg, and I. P. Touw: Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood 92, 32-39 (1998)
174. McLemore, M. L., J. Poursine-Laurent, and D. C. Link: Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest 102, 483-492 (1998)
175. Hunter, M. G., and B. R. Avalos: Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia. Blood 93, 440-446. (1999)
176. Ward, A. C., Y. M. van Aesch, J. Gits, A. M. Schelen, J. P. de Koning, D. van Leeuwen, M. H. Freedman, and I. P. Touw: Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-stimulating Factor (G-CSF) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-CSF Treatment. J Exp Med 190, 497-508 (1999)
177. Sinha, S., Q. S. Zhu, G. Romero, and S. J. Corey: Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 25, 791-796 (2003)
178. Druhan, L. J., J. Ai, P. Massullo, T. Kindwall-Keller, M. A. Ranalli, and B. R. Avalos: Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia. Blood 105, 584-591 (2005)
179. Gilliland, D. G.: Molecular genetics of human leukemias: new insights into therapy. Semin Hematol 39, 6-11 (2002)
180. Forbes, L. V., R. E. Gale, A. Pizzey, K. Pouwels, A. Nathwani, and D. C. Linch: An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene 21, 5981-5989. (2002)
181. White, S. M., M. H. Alarcon, and D. J. Tweardy: Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform. Blood 95, 3335-3340. (2000)
182. Awaya, N., H. Uchida, Y. Miyakawa, K. Kinjo, H. Matsushita, H. Nakajima, Y. Ikeda, and M. Kizaki: Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: relevance to the pathogenesis of myelodysplastic syndrome. J Cell Physiol 191, 327-335 (2002)
183. Wolfler, A., S. J. Erkeland, C. Bodner, M. Valkhof, W. Renner, C. Leitner, W. Olipitz, M. Pfeilstocker, C. Tinchon, W. Emberger, W. Linkesch, I. P. Touw, and H. Sill: A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome. Blood 105, 3731-3736 (2005)
184. Schnell, J. D., and L. Hicke: Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem 278, 35857-35860 (2003)